Skip to content

News

FDA Approves Drug to Identify Ovarian Cancer Lesions During Surgery

FDA Approves Drug to Identify Ovarian Cancer Lesions During Surgery

In what could prove to be a game-changer for ovarian cancer debulking procedures, the U.S. Food and Drug Administration (FDA) has approved Cytalux (pafolacianine), an imaging drug designed to help doctors better locate and identify ovarian cancer lesions during surgery. The drug, which is administered via injection at the time of surgery, works by binding … Continued

Bojana Stefanovska, PhD | Meet a Scientist

Bojana Stefanovska, PhD | Meet a Scientist

Dr. Bojana Stefanovska, at University of Minnesota Twin Cities, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. Her project, “APOBEC3B and DNA Repair as Synthetic Lethal Combinations in CCOC,” explores DNA repair as a potential treatment avenue for clear cell ovarian carcinoma (CCOC). What initially sparked your interest in science? … Continued

Ascites and Ovarian Cancer

Ascites and Ovarian Cancer

More than one-third of women with ovarian cancer develop ascites (pronounced uh٠SAI٠teez), an accumulation of fluid in the abdomen. Ascites, which also occurs in people with liver disease and occasionally with other conditions, can lead to bloating, pain, discomfort, nausea, as well as trouble moving around, eating, or breathing. While this fluid buildup often comes … Continued

A Thanksgiving Message from Audra Moran, President & CEO

A Thanksgiving Message from Audra Moran, President & CEO

Dear Friends, I hope this finds you all well, staying safe, and enjoying preparations for a lovely holiday. Whether you’re gathering with loved ones or holding them in your heart as you celebrate, I wish you warmth and joy. With the busy holiday season just around the corner, I’m grateful for this moment to reflect on … Continued

Working Out to Work Towards a Cure | Heroes Highlights

Working Out to Work Towards a Cure | Heroes Highlights

In this time of giving thanks, we want to take a moment to look back and express our gratitude for the OCRA Heroes who stepped up for September’s Ovarian Cancer Awareness Month to sweat it out at Ovarian Fitness events around the country, all in the name of raising funds for critical research, advocacy and … Continued

The Overview: November 2021

The Overview: November 2021

As we head into the Thanksgiving holiday, we have much to be thankful for … an embracing and strong survivor community, supporters who remain ever committed to the cause, and brilliant grantees who are making strides every day in the search for better treatments and a cure for ovarian cancer. Here’s a roundup of what’s … Continued

Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act

Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act

Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge. To address both financial barriers and inequity in participation, OCRA is urging Congress to pass the DIVERSE (Diversifying Investigations Via Equitable Research Studies for Everyone) Trials Act (H.R. 5030/S. … Continued

OCRA-Funded Study Points to New Approach to Improve Ovarian Cancer Treatment

OCRA-Funded Study Points to New Approach to Improve Ovarian Cancer Treatment

The following is a press release from University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, and Magee-Womens Research Institute PITTSBURGH, Nov. 12, 2021 – Immune checkpoint inhibitors are a type of cancer treatment that help the immune system’s T cells recognize and attack tumors. But these immunotherapy drugs aren’t effective against all cancers. In … Continued

Exercise and Ovarian Cancer

Exercise and Ovarian Cancer

Physical activity has been touted as important for a whole host of reasons, from bone health to mental health and everything in between. But what are the benefits of exercise for cancer patients, specifically ovarian cancer? And is it advisable for ovarian cancer patients to exercise at all? As always, it’s important to check with … Continued

Müllerian Clear Cell Carcinoma | April’s #RareAware Story

Müllerian Clear Cell Carcinoma | April’s #RareAware Story

April lives in Federal Way, Washington, and was diagnosed with Müllerian clear cell carcinoma. What has been your frustration in having a rare form of ovarian cancer? My biggest frustration is finding effective treatments and battling my insurance company to approve treatments. My insurance continues to deny treatments like immunotherapy, calling it investigational because there … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.